(secondQuint)Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive.

 This is an open-label study being conducted at 18 centers.

 The dose of 10 mg was chosen for daily continuous use of ulipristal acetate (UPA).

 The study will enroll approximately 300 subjects to use the UPA for 6 months (182 days).

 In addition to contraceptive efficacy, safety, overall acceptability of the product, and the number of bleeding/spotting days will be assessed.

.

 Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive@highlight

This is a Phase IIb multicenter, open-label, non-comparative trial of continuous daily oral 10 mg of ulipristal acetate (UPA) to evaluate its contraceptive efficacy as the primary method of contraception.

